Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine
Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma